Evidence map›Paper›PMID 16603716›Full record

ArticleRNA (New York, N.Y.)2006

Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.

Emily A Newman, Stephanie J Muh, Ruben H Hovhannisyan, Claude C Warzecha, Richard B Jones, Wallace L McKeehan, Russ P Carstens

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Fox-1 family of RNA-binding proteins.Cellular and molecular life sciences : CMLS · 2009
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emily A NewmanDepartment of Medicine, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA.
Stephanie J Muh
Ruben H Hovhannisyan
Claude C Warzecha
Richard B Jones
Wallace L McKeehan
Russ P Carstens

Funding

GROWTH FACTORS IN PROSTATE CANCERR01CA059971 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MCKEEHAN, WALLACE LEE · 1993 to 2007
$2.4M
REGULATION OF FGF RECEPTOR SPLICING IN PROSTATE CANCERR01CA093769 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CARSTENS, RUSS PAUL · 2003 to 2007
$1.3M
NCI NIH HHS CA093769NCI NIH HHS CA59971NCI NIH HHS R01 CA059971NCI NIH HHS R01 CA093769
6 · The paper itself

Abstract

We have developed a series of fluorescent splicing reporter minigenes for the establishment of cell-based screens to identify splicing regulatory proteins. A key technical advance in the application of these reporters was the use of two different fluorescent proteins: EGFP and monomeric Red Fluorescent Protein (mRFP). Through establishment of stable cell lines expressing such dual color fluorescent reporters, these minigenes can be used to perform enhanced screens for splicing regulatory proteins. As an example of such applications we generated fluorescent minigenes that can be used to determine the splicing of mutually exclusive FGFR2 exons IIIb and IIIc by flow cytometry. One minigene contained a coding sequence for EGFP whose translation was dependent on splicing of exon IIIb, whereas a second minigene required exon IIIc splicing for translation of an mRFP coding sequence. Stable incorporation of both minigenes into cells that express endogenous FGFR2-IIIb or FGFR2-IIIc resulted in EGFP or mRFP fluorescence, respectively. Cells stably transfected with both minigenes were used to screen a panel of cDNAs encoding known splicing regulatory proteins, and several were identified that induced a switch in splicing that could be detected specifically by an increase in green, but not red, fluorescence. We further demonstrated additional minigenes that can be used in dual color fluorescent screens for identification of splicing regulatory proteins that function through specific intronic splicing enhancer elements (ISEs). The methods and minigene designs described here should be adaptable for broader applications in identification of factors and mechanisms involved in alternative splicing of numerous other gene transcripts.

Indexed as

Alternative SplicingFlow CytometryFluorescent DyesGenes, ReporterBiological AssayCells, CulturedColorEnhancer Elements, GeneticGreen Fluorescent ProteinsIntronsLuminescent ProteinsModels, GeneticReceptor, Fibroblast Growth Factor, Type 2Recombinant Fusion ProteinsRed Fluorescent ProteinRNA-Binding Proteinsenhanced green fluorescent proteinFluorescent DyesGreen Fluorescent ProteinsLuminescent ProteinsReceptor, Fibroblast Growth Factor, Type 2Recombinant Fusion ProteinsRed Fluorescent ProteinRNA-Binding ProteinsTrans-Activators

Identifiers

PMID16603716
PMCPMC1464843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.